Walgreens Recalls Deferoxamine Infusions Due to Sterility Concerns
Walgreens Infusion Services is recalling Deferoxamine in normal saline due to a lack of sterility assurance. The products were distributed in six states.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The agency classified this as an FDA Class III recall, which is defined as unlikely to cause adverse health consequences. The hazard is a lack of sterility assurance, which fits the criteria for moderate severity in the absence of reported injuries or a higher agency classification.
Plain-English summary
Walgreens Infusion Services is recalling Deferoxamine in various strengths in normal saline. The recall was initiated because of a lack of sterility assurance for the product.
The affected products were distributed in Texas, Florida, Virginia, Georgia, Louisiana, and Mississippi. All products within their expiration dates are included in this recall.
Consumers should stop using the recalled product and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Deferoxamine various strengths in normal saline
- Manufacturer
- Walgreens Infusion Services
- Category
- Drug — Infusion Solution
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All products within expiry.
Distribution
Part of a larger recall action
This product is one of 36 recalled by Walgreens Infusion Services under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 36 products in this recall →Related recalls
Same manufacturer · Walgreens Infusion Services
See all →- SevereWalgreens Recalls IVIG Gamunex Bags Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
- SevereWalgreens Recalls Cefazolin Infusion Bags Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
- SevereWalgreens Recalls 0.9% Sodium Chloride/MVI Injection Bags Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
- SevereWalgreens Infusion Services Recalls Dextrose and Sodium Chloride Injection Bags
FDA (Drugs) · 2016-01-06
- HighWalgreens Recalls Famotidine Injection Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- SevereDeferoxamine Injection Syringes Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2016-06-08
- HighWalgreens Recalls Insulin Syringes Due to Sterility Assurance Concerns
FDA (Drugs) · 2016-01-06
- SevereWalgreens Recalls Dextrose and Sodium Chloride Infusion Bags Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
- SeverePharmedium Recalls Morphine Sulfate in 5% Dextrose Due to Sterility Concerns
FDA (Drugs) · 2018-02-28
- SeverePharmedium Recalls Dexamethasone Sodium Phosphate Infusions Due to Sterility Concerns
FDA (Drugs) · 2018-02-28
- SeverePharmedium Recalls Dexamethasone Sodium Phosphate Due to Sterility Assurance Issues
FDA (Drugs) · 2018-02-28